Skip to content

effectiveness of mindfulness-based relapse prevention group therapy among people with opioids use disorder

comparing the effectiveness of mindfulness-based relapse prevention group therapy with treatment as usual on shame, perfectionism and self-criticism among people with opioids use disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170702034844N5
Enrollment
30
Registered
2020-04-28
Start date
2019-07-23
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioids dependence. Opioid dependence

Interventions

Intervention 1: Intervention group: This group contains patients with opioid use disorder that aftermeeting interance critera will enter the group. At first, patients will fill the qustionarres of sha

Sponsors

Iranian National Center for Addiction Studies
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: age: 20 to 45 years old education: at least 8 grades opioids use disorder based on DSM-5 criteria informed consent for participating in research maitenance therapy with methadone or buprenorphine more than 1 week and less than 24 weeks

Exclusion criteria

Exclusion criteria: having psychotic syptoms organic brain disorder having suicide thoughts based on interiew meeting critera for personality disorder

Design outcomes

Primary

MeasureTime frame
Shame score other ad shamer scale. Timepoint: Before starting the treatment, after treatment, and 1 month after treatment. Method of measurement: Using other as shamer scale.;Scores in positive and negative perfectionism questionarre. Timepoint: Before starting the treatment, after treatment, and 1 month after treatment. Method of measurement: Using positive and negative perfectionism questionarre.;Scores in self-criticism questionarre. Timepoint: Before starting the treatment, after treatment, and 1 month after treatment. Method of measurement: Using self criticism questionarre.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Alireza Noroozi

Tehran University of Medical Sciences

a_r_noroozi@yahoo.com+98 21 5542 1155

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026